Guggenheim Maintains Buy on Absci, Raises Price Target to $15

Benzinga Newsdesk www.benzinga.com Positive 76.4%

Neg 0% Neu 0% Pos 76.4%

Guggenheim analyst Vamil Divan maintains Absci (NASDAQ:ABSI) with a Buy and raises the price target from $10 to $15.

Comments

No comments yet. Be the first!